MPR Weekly Dose 78 - Vaccine authorized for adolescents; Postoperative pain Tx approval; Insulin products recalled; Treatment Fast Tracked for facioscapulohumeral muscular dystrophy

<p><span style="font-weight: 400;">This week we have news of a COVID-19 vaccine authorization expanded for adolescents; A new postoperative pain treatment; There’s a new insulin smart pen devices; Insulin products are recalled; And the FDA grants fast track status to a potential treatment for the rare disease, FSHD.</span></p>